The first report from a phase II, multi-center clinical trial indicates that a newer, more aggressive form of radiation therapy -- stereotactic radiation -- can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life.
from Latest Science News -- ScienceDaily http://bit.ly/2S1DtXy
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment